Rosen Law Firm Urges Immutep Ltd. Shareholders to Explore Class Action Opportunities
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation
The Rosen Law Firm, a prominent advocate for investor rights globally, is actively investigating possible securities claims linked to Immutep Ltd. (NASDAQ: IMMP). This inquiry is prompted by recent allegations suggesting that the company may have provided misleading business information that could affect its shareholders negatively.
Background of the Investigation
On March 13, 2026, Immutep issued a press release which announced the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study. The committee recommended halting the trial evaluating eftilagimod alfa in patients with advanced non-small cell lung cancer following a planned interim analysis that indicated futility. Subsequently, the company declared that it would cease enrollment in the study and carry out an orderly wind-down process to meet regulatory and ethical obligations.
As a direct reaction to this news, the price of Immutep’s American Depositary Receipt (ADR) plummeted by 82.6%, dropping $2.28 to settle at $0.48 per ADR the same day. This dramatic decline has raised considerable concerns among investors about the integrity of information shared by the company leading up to this announcement.
Why You Should Act Now
If you've purchased securities from Immutep, you could potentially recover losses incurred as a result of this situation without any upfront costs, thanks to a contingency fee arrangement. The Rosen Law Firm is preparing to file a class action aimed at recouping investor losses, and they encourage affected shareholders to consider participating.
To join the proposed class action, shareholders should visit Rosen Law Firm's Submission Page or contact Phillip Kim, Esq. toll-free at 866-767-3653. Email inquiries can be sent to [email protected].
The Importance of Choosing Experienced Counsel
Selecting a qualified law firm is crucial in instances like this. The Rosen Law Firm advises investors to opt for experienced legal representation known for its successful track record in securities class actions. Many firms sending out notices lack necessary experience, resources, or the ability to litigate these cases effectively.
The Rosen Law Firm specializes in securities class actions and has successfully represented clients around the world. They have achieved significant settlements, including their record $438 million recovery for investors in 2019 alone. Their history of success has cemented their position as one of the leading firms in this area, with founder Laurence Rosen recognized as a top attorney by Law360.
Keep up to date with the latest information by following The Rosen Law Firm on their LinkedIn, Twitter, and Facebook pages.
Attorney Advertising: Please note that prior results do not guarantee similar outcomes in future cases. For more information or to discuss your potential claim, contact the Rosen Law Firm at:
- - Laurence Rosen, Esq.
- - Phillip Kim, Esq.
- - The Rosen Law Firm, P.A.
- - 275 Madison Avenue, 40th Floor
- - New York, NY 10016
- - Tel: (212) 686-1060
- - Toll-Free: (866) 767-3653
- - Fax: (212) 202-3827
- - Email: [email protected]
- - Website: www.rosenlegal.com
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.